Top Markets
#1 GEKKO GEKKO +53.94%
#2 ADO Protocol ADO Protocol +38.79%
#3 Pons Pons +37.50%
#4 Prom Prom +32.61%
#5 Helium Helium +28.33%
#6 TENDIES TENDIES +25.51%
#7 Giggle Fund Giggle Fund +18.81%
#8 龙虾 (Lobster) 龙虾 (Lobster) +18.72%
#9 Main Street Yield Main Street Yield +17.48%
#10 o1.exchange o1.exchange +17.29%
Coin of the day
GEKKO GEKKO
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Hubei Biocause Pharmaceutical Co., Ltd. Hubei Biocause Pharmaceutical Co., Ltd.

Hubei Biocause Pharmaceutical Co., Ltd.

000627
Classifica tra le azioni #9082
Hubei Biocause Pharmaceutical Co., Ltd., based in Jingmen, China, operates a... Hubei Biocause Pharmaceutical Co., Ltd., based in Jingmen, China, operates a multifaceted business. Its primary activities within China involve the provision of life and motor insurance policies. Additionally, the company is engaged in the pharmaceutical, chemical, and new energy fuel industries. Specifically, in the pharmaceutical field, it conducts contract research, development, and manufacturing of active pharmaceutical ingredients (APIs), intermediate compounds, and various drug forms such as tablets, granules, and capsules. Its chemical offerings include substances like dimethyl ether gas and a-chloropropionyl chloride. The firm also boasts an international presence, distributing its products to markets including the United States, the European Union, and other global locations.
Prezzo delle azioni
$0.2219522
Ultima sincronizzazione: 2025-09-11
Capitalizzazione di mercato
$1.10B
Variazione (1 giorno)
0.04%
Variazione (1 anno)
0.17%
Paese
CN
Scambia Hubei Biocause Pharmaceutical Co., Ltd. (000627)

Categoria

Financial Services
Rapporto P/S per Hubei Biocause Pharmaceutical Co., Ltd. (000627)
Rapporto P/S al August 2026 TTM: 0.16
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Hubei Biocause Pharmaceutical Co., Ltd., il rapporto P/S attuale (TTM) è 0.16. Alla fine del 2022, era pari a 0.31.
Storico del rapporto P/S per Hubei Biocause Pharmaceutical Co., Ltd. da 2000 a 2026
Rapporto P/S alla fine di ogni anno
Anno Rapporto P/S Cambia
2026 (TTM) 0.16 -44.32%
2023 0.28 -9.91%
2022 0.31 -4.58%
2021 0.33 -40.28%
2020 0.55 -20.19%
2019 0.69 -22.30%
2018 0.89 32.65%
2017 0.67 -63.11%
2016 1.82 -93.34%
2015 27.32 249.63%
2014 7.81 114.32%
2013 3.65 -23.01%
2012 4.73 38.93%
2011 3.41 -36.39%
2010 5.36 1.98%
2009 5.25 133.47%
2008 2.25 -70.72%
2007 7.69 165.80%
2006 2.89 172.12%
2005 1.06 -63.15%
2004 2.88 -20.44%
2003 3.62 -72.89%
2002 13.37 64.55%
2001 8.12 4.25%
2000 7.79 0.00%
Rapporto P/S per aziende simili o concorrenti
Azienda Rapporto P/S Differenza del rapporto P/S Il paese
China Life Insurance Company Limited China Life Insurance Company Limited
China Life Insurance Company Limited
601628.SS
2.00 1,183.26%
CN
AIA Group Limited AIA Group Limited
AIA Group Limited
1299.HK
3.05 1,856.45%
HK
Manulife Financial Corporation Manulife Financial Corporation
Manulife Financial Corporation
MFC.TO
- -
CA
Fubon Financial Holding Co., Ltd. Fubon Financial Holding Co., Ltd.
Fubon Financial Holding Co., Ltd.
2881.TW
- -
TW
MetLife, Inc. MetLife, Inc.
MetLife, Inc.
MET.US
- -
US